Comorbidities... a study from the German CLL S... - CLL Support
Comorbidities... a study from the German CLL Study Group
You need to be a member of this community to see this post.
Read more about...
You need to be a member of this community to see hidden responses.
Not what you're looking for?
You may also like...
CLL INFORMATION - A developing reliable and current international list of CLL Information & Resources.
We have opened a thread that provides access to many of the key reliable UK and international...
Acalabrutinib, venetoclax and obinutuzumab in relapsed CLL: Phase 2 CLL2-BAAG trial results from the German CLL Study Group
Some very encouraging news for those with unmutated IGHV and/or TP53 aberrations, who are wondering...
Skin Cancer and CLL a Mayo community study...
'Patients with CLL are at higher risk of developing melanoma and other skin malignancies. The...
Treatment-naive or relapsed CLL patients will soon have zanubrutinib/Brukinsa as a treatment option in the EU
The EC approval is based on positive results from two Phase 3 clinical trials: SEQUOIA...
CLL - a Cancer of the Immune System
By understanding how CLL impacts our bodies and taking the necessary precautions, we can greatly...
Related Posts
- Video - Panel discussion from the CLL Support Association UK Patient Meeting in Cambridge, 21st June, 2014
The inaugural CLL Tribune- Questionable Online Advice from a Physician about CLL
Canadian Study...treatment increases risk of secondary cancers in CLL- Reflections from Cardiff, news of CLL research and the changing trials landscape
